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Summary
 
The understanding of human thymic function and evaluation of its contribution to T cell ho-
meostasis are matters of great importance. Here we report the development of a novel assay to
quantitate the frequency and diversity of recent thymic emigrants (RTEs) in the peripheral
blood of humans. Such cells were defined by the presence of T cell receptor (TCR) rearrange-
ment deletion circles (DCs), episomal byproducts of TCR-
 
b
 
 V(D)J rearrangement. DCs were
detected in T cells in the thymus, cord blood, and adult peripheral blood. In the peripheral
blood of adults aged 22 to 76 years, their frequency was highest in the CD4
 
1
 
CD45RA
 
1
 
CD62L
 
1
 
 subpopulation of naive T cells. TCR DCs were also observed in other subpopula-
tions of peripheral blood T cells, including those with the CD4
 
1
 
CD45RO
 
2
 
CD62L
 
1
 
 and
CD4
 
1
 
CD45RO
 
1
 
CD62L
 
1
 
 phenotypes. RTEs were observed to have more than one V
 
b
 
 rear-
rangement, suggesting that replenishment of the repertoire in the adult is at least oligoclonal.
These results demonstrate that the normal adult thymus continues to contribute, even in older
individuals, a diverse set of new T cells to the peripheral circulation.
Key words: thymus • T cell receptor • deletion circles • naive T cells • immune reconstitution
 
I
 
t has been assumed that a diverse TCR repertoire is
formed during early life, when the thymus is most active,
and that T cell homeostasis is maintained without signifi-
cant thymic input in adults (1, 2). Given the profound ef-
fects of stress on thymopoiesis, intrathymic T cell produc-
tion in the intact animal is best studied with a minimally
invasive assay for recent thymic emigrants (RTEs)
 
1
 
 in the
peripheral blood. In the chicken, for example, RTEs can
be identified by their unique expression of the cell surface
marker chT1 (3). Murine RTEs may be followed kineti-
cally in the peripheral circulation after direct intrathymic
labeling, e.g., with FITC (4). Assays of this type are, how-
ever, unavailable for the assessment of human thymic func-
tion. Such assessment has relied instead upon autopsy series
(5), radiographic observations (6), and/or phenotypic de-
marcation of circulating human T cells into distinct popu-
lations of “naive” or “memory/effector” cells. In aggregate,
these studies (7) demonstrate that: (a) there is a correlation
between the abundance of circulating CD4
 
1
 
CD45RA
 
1
 
CD62L
 
1
 
 human T cells and the presence of thymic tissue
(7–9), suggesting that RTEs are included within this T cell
subpopulation; (b) the circulating CD8
 
1
 
CD45RA
 
1
 
 T cell
subpopulation is less clearly associated with human thymic
tissue (8); and (c) circulating memory/effector CD4
 
1
 
 and
CD8
 
1
 
 T cell subpopulations bear the phenotypic marker
CD45RO instead of CD45RA (10).
Phenotypic measures are imprecise, however, in their
ability to distinguish lymphocytes that have recently been
made in the thymus or peripheral tissues and those that
have reverted from memory status (11, 12). Thus, although
it is clear that the human thymus involutes dramatically af-
ter puberty (5), the fraction of circulating CD45RA
 
1
 
 T
 
1
 
Abbreviations used in this paper:
 
 CBMCs, cord blood mononuclear cells;
DCs, deletion circles; DCF, deletion circle frequency; RAG, recombina-
tion activating gene; RSS, recombination signal sequences; RTEs, recent
thymic emigrants; SP, single positive.
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cells remains relatively constant for long periods of time
thereafter (13). These findings suggest that the CD45RA
 
1
 
CD62L
 
1
 
 T cell subpopulation may contain a higher pro-
portion of RTEs earlier rather than later in life and that it
harbors heterogeneous cell populations (including rever-
tants of memory/effector cells) throughout life.
Recently, Douek et al. (14) have exploited an intrinsic
feature of the TCR rearrangement process to directly dem-
onstrate the presence of continuous thymic output in hu-
man adults. This assay relies on the detection of TCR-
 
a
 
excision circles (
 
a
 
TRECs) generated during TCR-
 
a
 
 gene
rearrangement in the thymus. Similar observations have
also been made in the avian system, whereby de novo
TCR rearrangement, as measured by excision circle assays,
correlated with the expression of chT1 antigen (15). More-
over, circle-bearing T cells were found in the avian lymph
node, spleen, and skin (16), suggesting that the thymus may
constantly supply new T cells to these peripheral compart-
ments.
In this report, we describe an assay for the detection of
RTEs within various subpopulations of circulating human
T cells. We observe that such cells are most abundant in
the CD45RA
 
1
 
CD62L
 
1
 
 subpopulation, that they are at
least oligoclonal in their expression of TCR V
 
b
 
 regions,
and that they are detectable in adults.
 
Materials and Methods
 
Isolation of Thymocytes.
 
Methods for maintenance of  SCID-hu
mice and harvest of thymocytes from SCID-hu Thy/Liv organs
were identical to those previously published (17). In some cases,
SCID-hu Thy/Liv organs were harvested and placed in RPMI
1640 media (Life Technologies) supplemented with 10% FCS
(Summit Biotechnology) and transported overnight at 4
 
8
 
C before
harvest of thymocytes. After isolation, thymocytes were resus-
pended in PBS supplemented with 2% FCS and kept on ice be-
fore staining with mAbs for flow cytometric analysis or cell sort-
ing. All procedures and practices were approved by the University
of California, San Francisco Committee on Human Research
(CHR) or Committee on Animal Research.
 
Isolation of  PBMCs.
 
Whole blood samples from human sub-
jects were collected by phlebotomy into EDTA collection tubes
(Becton Dickinson). PBMCs were isolated from whole blood by
density–gradient centrifugation (Life Technologies). PBMCs
were washed twice with PBS before resuspension in PBS supple-
mented with 2% FCS before staining with mAbs for flow cytom-
etry or cell sorting.
 
Stimulation of Cord Blood Cells In Vitro.
 
Human umbilical cord
blood cells were obtained (with CHR approval) from healthy de-
livery specimens and placed in heparinized collection tubes (Bec-
ton Dickinson) under sterile conditions. Cord blood mononu-
clear cells (CBMCs) were isolated as described above for whole
blood specimens and resuspended at a concentration of 2 
 
3
 
10
 
6
 
 cells/ml in RPMI 1640 supplemented with 10% human AB
serum (Ultraserum; Gemini Bio-Products). CBMCs were then
cultured (at 37
 
8
 
C in 5% CO
 
2
 
) for 48, 72, or 96 h or 9 d (time
points encompassed in two different experiments) and stimulated
with 5 
 
m
 
g/ml of PHA (Sigma Chemical Co.) and 10 U/ml puri-
fied IL-2 (Boehringer Mannheim). The supplemented medium
was changed every 3 d. Cell culture controls did not receive
 
PHA or IL-2 stimulation but were cultured for 72 h in the same
medium. Aliquots of  the cell cultures at different time points
were analyzed by flow cytometry for the expression of the cell
surface markers CD45RA and CD62L.
 
Immunophenotypic Analysis and Cell Sorting by Flow Cytometry.
 
PBMCs, thymocytes from SCID-hu mice, or CBMCs were
stained with fluorescent-conjugated mABs specific for cell surface
markers at a concentration of 10
 
7
 
 cells/ml at 4
 
8
 
C for 30 min. Af-
ter staining, cells were washed with PBS supplemented with 2%
FCS and sorted on either a FACStar™ or FACS Vantage™ cell
sorter (both from Becton Dickinson). The cells were stained with
one of the following antibody combinations: (a) anti-CD8–FITC
and anti-CD4–PE (Becton Dickinson); (b) anti-CD45RA–FITC
or anti-CD45RO–FITC (Immunotech), anti-CD62L–PE (Bec-
ton Dickinson), and anti-CD4–ECD (Coulter Immunology); (c)
anti-CD62L–FITC, anti-CD45RA–PE (PharMingen), and anti-
CD4–tricolor or anti-CD4–allophycocyanin (Caltag Labs., Inc.).
Sort purities were checked after each sort and were 
 
$
 
97%. For
analysis of cord blood CD45RA and CD62L expression, CBMCs
were stained with anti-CD45RA–FITC (Immunotech) and anti-
62L–PE (Becton Dickinson) and analyzed using a FACScan™
cytometer and CELLQuest™ software (both from Becton Dick-
inson).
 
Detection of TCR-
 
b
 
 Rearrangement Deletion Circles.
 
Total DNA
from distinct cell populations was extracted and purified via a
standard protocol (18) before spectrophotometric quantitation at
260 and 280 nm. The freshly isolated DNA was stored at 4
 
8
 
C for
further processing. Thermal cycling was performed for 30 cycles
(1 min at 94
 
8
 
C, 1.5 min at 65
 
8
 
C, and 1.5 min at 72
 
8
 
C) for each
round of a seminested PCR protocol designed to detect V
 
b
 
D
 
b
 
-
specific deletion circles (DCs) generated by TCR-
 
b
 
 recombina-
tion. All first and second round primers were generated to fully
hybridize with noncoding regions of the TCR-
 
b
 
 locus (19) lo-
cated next to the recombination signal sequences (RSS; available
from EMBL/GenBank/DDBJ under accession numbers U66059,
U66060, and U66061; see Table I). Four PCR replicates were
performed on each total DNA serial dilution to ensure a precise
readout for each experiment. Concentrations of total DNA were
adjusted so that a constant volume of 3 
 
m
 
l was added to each 50-
 
m
 
l PCR reaction (200 
 
m
 
M dNTPs, 1
 
3
 
 PCR buffer [Boehringer
Mannheim], 100 ng of each primer, and 2 U of Taq polymerase
[Boehringer Mannheim]). From the first PCR amplification, 3 
 
m
 
l
of the first PCR product was used as template for the second
(seminested) PCR reaction (under the same conditions) using the
“Circle” primer and the DC-D
 
b
 
1 primer.
 
Quantitative Analysis of Endpoint Dilutions.
 
Second round PCR
products were visualized with ethidium bromide on 1.25% agar-
ose gels and digitally photographed. Individual amplifications
were scored as positive or negative by two observers. The highest
dilution returning a positive amplification was taken as the end-
point for each dilution series. Dilution series with more than two
“skipped” wells (i.e, a failed amplification followed by a success-
ful amplification at higher dilution) were omitted from the analy-
sis. The abundance of DCs was estimated by the Reed-Muench
method (20, 21). This method uses information from replicate
dilution series to estimate an endpoint (measured in terms of nano-
grams of input DNA) in which 50% of samples were positive for
DCs (the 50% DC endpoint). The DC frequency (DCF) was ar-
bitrarily defined as the reciprocal of  the 50% DC endpoint 
 
3
 
100. Alternatively, the seminested PCR data were analyzed by a
maximum likelihood estimated method of dilution endpoint with
a parametric method (22). Unlike the Reed-Muench method,
this method returns an estimate of goodness of fit of the data to
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the estimated endpoint. Endpoints estimated by the two methods
were highly correlated (
 
r
 
2
 
 5 
 
0.929), and the choice of method
did not alter the conclusions drawn from the data. The degree of
inter- and intraassay variation was assessed by performing two in-
dependent experiments on two different samples from the same
individuals (
 
n
 
 5 
 
3) and ranged on the order of  two- to threefold
(data not shown).
 
Results and Discussion
 
A Novel Assay to Identify RTEs.
 
To determine whether
the CD4
 
1
 
CD45RA
 
1
 
CD62L
 
1
 
 subpopulation of circulating
human T cells contains RTEs, we devised an assay to de-
tect physical evidence of recent TCR gene rearrangement.
We chose to focus on rearrangements at the 
 
b
 
 locus be-
cause the complete sequence of this locus has been ob-
tained (19), permitting the construction of a panel of V
 
b
 
-
specific primers to assess the diversity of rearranged TCRs.
Moreover, allelic exclusion is more complete at the TCR
 
b
 
 locus than at the TCR-
 
a
 
 locus (23, 24). Rearrangements
at this locus are a salient feature of intrathymic T cell pro-
duction and require expression of the recombination acti-
vating genes ([RAG]-1 and RAG-2) and recognition of
conserved heptamer and nonamer RSS flanking each V, D,
and J gene segment (25–29; Fig. 1 A). As the coding seg-
ments are brought together, excision–ligation of the hep-
tamer–heptamer signal joint creates an episomal TCR rear-
rangement DC (25, 30) bearing two identifiers: first, each
V
 
b
 
-D
 
b
 
 DC has a precise molecular mass determined by
the length of intervening, noncoding DNA; second, a
unique DNA sequence bridges the signal joint. Using the
known nucleotide sequences of the noncoding DNA re-
gions adjacent to V
 
b
 
2, V
 
b
 
17, V
 
b
 
5.1, and D
 
b
 
1 (19), prim-
ers were designed such that a PCR product would only be
amplified if the primers were facing each other within a
closed DC (Table I). As shown in Fig. 1 B, the product
amplified for a V
 
b
 
2/D
 
b
 
1 rearrangement would have a pre-
dicted size of 439 bp, with characteristic restriction enzyme
sites. In the case of DCs specific for V
 
b
 
17/D
 
b
 
1 and
V
 
b
 
5.1/D
 
b
 
1 rearrangements, the corresponding molecular
masses would be 445 and 442 bp, respectively.
The specificity and reliability of this strategy was first as-
sessed in developing human thymocytes, expected to have
a high frequency of DCs (31). DNA was extracted from
two different samples of human CD4
 
1
 
CD8
 
1
 
 thymocytes
(harvested from Thy/Liv organs of SCID-hu mice) (17).
After amplification using the primers specific for V
 
b
 
2/D
 
b
 
1
DCs, all were found to generate the expected 439-bp PCR
product. As shown in a representative case (Fig. 1 B), this
product carried predicted restriction enzyme recognition
sites for Sac1, PvuII, and ApaL1 and was not observed with
PCR performed on DNA from Jurkat cells (a V
 
b
 
8.1 T cell
line that should not carry V
 
b
 
2/D
 
b
 
1 DCs). Nucleotide se-
quence analysis of the PCR product confirmed its identity
to the predicted sequence spanning the signal joint of the
V
 
b
 
2/D
 
b
 
1 DC (not shown).
 
Quantitative Assessment of Cells Having Recently Undergone
b Chain TCR Rearrangement. Within a population of
cells, the fraction bearing DCs should be proportional to
that which has recently undergone TCR rearrangement.
To directly compare this fraction among different cell pop-
ulations, a semiquantitative assay was developed to measure
a dilution endpoint of DC DNA within a given amount of
total cell DNA. DNA was diluted in four replicate series,
and PCR was carried out to determine whether a given
well was positive or negative for the DC PCR product.
The 50% DC endpoint, measured in terms of nanograms of
input DNA, was calculated using either the Reed-Muench
method (20, 21) or a maximum likelihood estimate (22)
(see Materials and Methods). The 50% DC endpoint repre-
sents the median minimal amount of DNA from which a
DC may be amplified by nested PCR; the DCF was arbi-
trarily defined as the reciprocal of the 50% DC endpoint 3
100 and is proportional to the number of DCs that can be
amplified from 100 ng of input DNA. A representative
experiment using the assay to quantitate DCs is shown in
Fig. 2 A. Four replicate dilution series of DNA from CD31
CD81 single positive (SP) thymocytes were amplified with
primers specific for Vb2/Db1 DCs, and these yielded a
positive PCR signal for DCs at final (highest) dilutions of
16, 16, 16, and 3.2 ng input DNA. This corresponds to a
50% DC endpoint of 5.47 ng (as determined by the Reed-
Muench method) and a DCF of 18.3 (100/5.47). Assuming
typical recovery of DNA and amplification sensitivity, this
would return a minimum estimate of 1 DC in 547 SP8
thymocytes, or, as 2–5% of the total express a Vb2/Db1
TCR, 11–22 Vb2/Db1 SP8 thymocytes. Similar frequen-
cies of DCs were noted in sorted populations of
CD31CD41 and CD41CD81 thymocytes, yielding DCFs
of 8.4 and 11.7, respectively (Fig. 2 B).
TCR Vb DCs in Circulating Peripheral Blood T Cells. As
prior studies indicated that DCs were detectable within
chT11 RTEs in chickens (3) and in human children and
adults (14, 32), the Vb DC assay was used to determine
whether Vb DCs were present in various populations of
human peripheral blood T cells. Reasoning that the fre-
quency of RTEs in the peripheral blood would be highest
early in life, T cells in cord blood were examined first.
Flow cytometric analysis revealed that .95% of CD41 T
cells in unstimulated cord blood carried the “naive”
CD45RA1 CD62L1 phenotype (Fig. 3 A, panel 1), and all
Table I. Primary Sequence of Primers Required for
bDC Detection/Amplification
Primer name Nucleotide sequence
DC-Vb2 59-gcacacacactcccagatgtctcagtcaggaaagc-39
DC-Vb5.1 59-ttttccccagccctgagttgcagaaagcccc-39
DC-Vb17 59-cgtttcctgccatcatagagtgcagaggagccctgt-39
DC-Db1 59-gtcatagcttaaaaccctccgagtgacgcacagcc-39
Circle-Vb2 59-ggagggcagctgcaggggttcttgc-39
Circle-Vb5.1 59-ccacattgggccagggaggtttgtgc-39
Circle-Vb17 59-gtcggggaagcaggactgggcacatttatgc-39
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Figure 1. Formation and detection
of TCR-b rearrangement DCs. (A)
Top: genomic organization of the re-
gion including the Vb2 and Db1 cod-
ing segments, flanked by heptamer and
nonamer RSS and 170 kbp of inter-
vening noncoding DNA. Bottom:
generation of a rearranged Vb2/Db1
coding TCR and a 170-kbp Vb2/
Db1 DC after excision–ligation medi-
ated by RAG-1 and RAG-2. The rel-
ative location and orientation of the
primers used for amplification of the
unique signal joint are shown. Note
that DCs will have various sizes (from
65 to 588 kbp) depending on the Vb-
Db usage. (B) Top: map of the ampli-
fied 439-bp Vb2/Db1 PCR product.
Bottom: representative example of
Vb2/Db1 DC products amplified
from CD41CD81 human thymocytes
or from Jurkat cells. The left gel shows
the specificity of the amplification;
note the absence of products in both
the Jurkat and “no DNA” lanes. The
PCR product is partially cleavable by
ApaLI, likely due to heterogeneity of
nucleotide sequence at the circle junc-
tion. An ApaLI digestion-positive con-
trol was performed at the same time on
an empty pBS vector, resulting in
complete digestion. The right gel
shows restriction analysis of the puri-
fied 439-bp Vb2/Db1 DC product,
with characteristic cuts by SacI, PvuII,
and ApaLI. White arrow, 55-bp frag-
ment released by ApaLI digestion.
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of these cells were “bright” for CD45RA staining. The fre-
quency of DCs within unstimulated cord blood was higher
than that observed for SP thymocytes (with DCFs approxi-
mating 43.1 and 41.8 in the two cord blood specimens
compared with values of 18.3 and 8.4 for SP8 and SP4 thy-
mocytes, respectively) (Fig. 3 B). After 9 d of stimulation in
vitro with PHA and IL-2, the percentage of CD41 cord
blood T cells with the naive (CD45RAbrightCD62L1) phe-
notype dropped to negligible levels, and most cells were
instead negative for CD62L and/or dimly positive for
CD45RA (Fig. 3 A, panels 2–4). Within this same time
frame, the frequency of DCs dropped from an average of
42.5 to 0.85 DCF, a 50-fold decrease over a 9-d period
(Fig. 3 B). These results indicated that DCs could be de-
tected in circulating T cells and that their detection was
correlated with the presence of cells bearing the naive
CD45RA1CD62L1 phenotype.
Inverse Correlation between Frequencies of DCs and Age.
DCs were then quantitated in the peripheral blood of 17
adult individuals, ranging in age from 22 to 76 yr. In each,
naive CD41CD45RA1CD62L1 and memory/effector CD41
CD45RO1CD62L2 cells were quantitated by flow cytom-
etry and sort-purified for determination of DC frequency.
Results are shown in Fig. 3 C. Within the population of
circulating CD41CD45RA1CD62L1 T cells, DCs were ob-
served with a frequency that was higher than that found in
the CD41CD45RO1CD62L2 population (which had non-
detectable levels of  DCs in these 17 individuals; data not
shown). As a function of age, there was a consistent decrease
in the frequency of DCs within the CD41CD45RA1
Figure 2. Quantitation of TCR rearrangement DCs. (A) Representative
example of endpoint dilution analysis of DCs within CD31CD81 human
thymocytes. Starting at 2,000 ng of input DNA per well, quadruplicate
fivefold serial dilutions were subjected to the nested PCR approach shown in
Fig. 1. DNA from Jurkat cells (150 ng) and from total thymocytes (150
ng) served as negative and positive controls, respectively. (B) Relative fre-
quencies of Vb2/Db1 DCs in sort-purified populations of CD41CD81,
CD31CD41CD82, and CD31CD42CD81 human thymocytes.
Figure 3. Detection of TCR rearrange-
ment DCs in human peripheral blood T cells.
(A) Representative flow cytograms of CD41
human cord blood T cells that were unstimu-
lated (panel 1) or stimulated for varying time
intervals (panel 2, 72 h; panel 3, 96 h; panel
4, 9 d) with IL-2 (10 U/ml) and PHA (5
mg/ml). CD41 T cells at each time point
were gated and subdivided by staining for
CD45RA and CD62L. Based on the staining
of cells for CD45RA before stimulation
(panel 1), cells were designated as
CD45RAbright or CD45RAdim (with fluores-
cence intensities above and below the dotted
lines, respectively). (B) Relative frequency of
Vb2/Db1 DCs in cord blood T cells that
were unstimulated (control) or stimulated for
varying time intervals with PHA and IL-2.
Black bars, results from one experiment with
endpoints at 48 and 72 h; white bars, results
from a second experiment (different cord
blood donor) with endpoints at 72 h and 9 d.
(C) Correlation between increasing age and
decreasing frequency of Vb2/Db1 DCs in
the circulating CD41CD45RA1CD62L1 T
cell subpopulation (P 5 0.0045). Sort-puri-
fied CD41CD45RA1CD62L1 human pe-
ripheral blood T cells were isolated from in-
dividuals of the indicated ages and analyzed
for Vb2/Db1 DCs. Such DCs were absent from the CD41CD45RO1CD62L2 subpopulations of each individual (not shown). The point at 55 yr old
was scored as “undetectable” in the assay (i.e., with a DCF value #0.1). (D) Percentages of circulating naive (CD45RA1CD62L1) CD41 T cells in the
peripheral blood as a function of age. No correlation exists between age and the frequency of such naive CD41 T cells (P 5 0.5123).
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CD62L1 subpopulation (Fig. 3 C; r2 5 0.5026, P 5
0.0045), even though individuals across this age range had
equivalent percentages of CD45RA1CD62L1 within their
CD41 T cells (Fig. 3 D; r2 5 0.0233, P 5 0.5123). These
data suggest that RTEs exist within the circulating popula-
tion of CD41CD45RA1CD62L1 T cells of adults, that
their proportion decreases with age, and that the DC assay
appears to provide a much more reliable estimate of de novo–
generated T cells than that provided by phenotypic cell
surface markers such as CD45RA and CD62L.
Detection of DCs in Other T Cell Populations. To deter-
mine whether other subpopulations of circulating CD41 T
cells might harbor TCR-b rearrangement DCs, cells were
sort-purified into subpopulations that were CD41CD45RA1
CD62L1, CD41CD45RO1CD62L2, CD41CD45RO1
CD62L1, and CD41CD45RO2CD62L1. In eight indi-
viduals ranging in age from 22 to 76 yr, the highest fre-
quency of DCs was found in the CD45RA1CD62L1 sub-
populations and the lowest in the CD45RO1CD62L2
subpopulation (Table II). DCs were also found in the
CD45RO1CD62L1 subpopulation in four out of eight in-
dividuals tested, albeit at a lower frequency. Finally, DCs
were detected in T cells with the phenotype CD45RO2
CD62L1 (data not shown) and CD45RO1CD62L2, al-
though only one out of nine individuals showed detectable
levels of DCs in the latter compartment. These cells may
possibly represent direct progeny of RTEs in the
CD45RA1CD62L1 subpopulation; alternatively, DCs may
be present within them as a consequence of extrathymic
TCR rearrangements (1, 33).
The TCR Repertoire in RTEs Is at Least Oligoclonal. Previ-
ous studies have demonstrated the presence but not the de-
gree of TCR diversity of RTEs in adult humans (14, 32).
To address this parameter of diversity, we generated prim-
ers that could amplify DCs issued from three different
TCR Vb-Db rearrangements (Vb2/Db1, Vb5.1/Db1,
and Vb17/Db1). Flow cytometric analyses (not shown) re-
vealed different percentages of circulating T cells bearing
these three Vbs (Vb2: 8–10%; Vb5.1: 3–4%; and Vb17:
3–4%). Results illustrated in Table II clearly show that DCs
detectable in circulating human T cells encompass several
(at least two) Vbs and were present not only in the
CD45RA1CD62L1 but also in the CD45RO1CD62L1
subpopulations of CD41 T cells. Interestingly, the relative
frequency of DCs from different Vb regions, as measured
by flow cytometry, did not correlate with the proportion
of PBLs expressing these TCR Vb products. For instance,
Vb21 T cells were always at least twofold more abundant
in PBLs from normal individuals compared with Vb5.11 or
Vb171 T cells (data not shown). Yet analysis of DCF val-
ues (shown in Table II) indicated that, in the two individu-
als tested (aged 31 and 32 yr), Vb5.1/Db1 or Vb17/Db1
Table II. The TCR Repertoire of RTEs Is at Least Oligoclonal
Age 22 23 25 28 31 32 39 76a 76b
*Frequency (%)
CD41CD45RA1CD62L1 32 30 25 36 52 59 35 44 62
CD41CD45RO1CD62L1 18 25 28 42 38 25 18 43 33
CD41CD45RO1CD62L2 39 19 32 13 9 10 23 6 4
‡ TCR Vb2 (%) ND ND 8 ND 6 ND ND 9 9
§DCF (Vb2/Db1 DC)
CD41CD45RA1CD62L1 1.67 10.12 1.46 3.63 0.50 1.37 0.17 0.50 0.33
CD41CD45RO1CD62L1 0.50 ND 0.73 ND 0.75 ,0.1 ND ,0.1 0.1
CD41CD45RO1CD62L2 0.22 ,0.07 ,0.1 ,0.1 ,0.1 ,0.1 ,0.1 ,0.1 ND
§DCF (Vb5.1/Db1 DC)
CD41CD45RA1CD62L1 ND ND ND ND 0.29 7.97 ND ND 0.71
§DCF (Vb17/Db1 DC)
CD41CD45RA1CD62L1 ND 1.72 ND 0.85 1.12 ND 0.37 ND ND
Summary of DCF values for multiple TCR Vb-Db rearrangements in FACS™-sorted subpopulations of CD41 T cell subpopulations.
*Frequency of each sort-purified subpopulation within CD41 T cells.
‡Flow cytometry–derived percentages of TCRVb21 T cells found in the CD41 T cell population.
§DCs from different Vb rearrangements were quantitated in the naive (CD45RA1CD62L1) and memory/effector (CD45RO1CD62L2 and
CD45RO1CD62L1) CD41 T cell subpopulations of healthy adults, as described in Materials and Methods. The frequency of TCRVb21CD41 T
cells (b) remains quite constant with increasing age, whereas the corresponding DCF trend (c) decreases.
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DCs were two- to fivefold more abundant than Vb2/Db1
DCs. These differences in the relative abundance of Vb DCs
compared with the expected frequencies of their parental
cell populations could reflect a relative dilutional effect on
some Vb DCs due to varying degrees of peripheral expan-
sion in Vb-specific subsets, as well as a relative overestimate
of some subpopulations due to the detection of DCs from
nonproductive rearrangements that might be more preva-
lent in certain Vb subsets.
In sum, these experiments demonstrate that TCR-b
DCs can be detected within thymocytes and circulating
human CD41 T cells with a naive (CD45RA1CD62L1)
phenotype. Detection of such circles is specific, reliable,
and quantitative; our method also indicates that they are
generated upon rearrangement of multiple Vb coding seg-
ments. Finally, DCs in CD41CD45RA1CD62L1 T cells
are observed in a pattern that is consistent with known pa-
rameters of intrathymic maturation: their frequency de-
creases as cord blood T cells are stimulated to divide in
vitro and in older individuals who have less active thymi, as
measured in autopsy series or by noninvasive radiography.
As such, quantitation of DCs within human peripheral
blood CD41CD45RA1CD62L1 T cells appears to repre-
sent a measure of  RTEs and, hence, thymic function.
These results serve to directly confirm previous infer-
ences about thymic function. First, the finding of DCs
within the CD41CD45RA1CD62L1 population of adult
individuals aged 23–76 yr underscores the premise that the
thymus, though less functional, is nonetheless operative
into adulthood (2, 5, 9, 14, 32). Secondly, the fact that
the frequency of DCs decreases in the CD41CD45RA1
CD62L1 population as a function of age demonstrates that
this population is heterogeneous (11, 12) and that its com-
position is age dependent. It may not be useful, in other
words, to assume that the presence (or reappearance) of
such cells is synonymous with “immune reconstitution”
(34–37). Finally, the finding of DCs within other popula-
tions of circulating T cells raises the possibility that ex-
trathymic sources (e.g., gut or liver) may contribute to for-
mation of the circulating TCR repertoire (1, 33).
Although further work is required to optimize the quan-
titative precision of the DC assay and enhance its applica-
bility for comprehensive studies of human thymic func-
tion, it is now applicable to important contemporary
questions about thymic function and immune reconstitu-
tion in humans. Most immediately, it will be of interest to
determine the extent of thymic dysfunction at different
stages of HIV infection and after bone marrow reconstitu-
tion postmyeloablation. It will also be interesting to deter-
mine the extent of de novo rearrangement in lymph nodes,
which might be induced by chronic viral replication, as re-
cently suggested in a murine model of persistent antigen
exposure (38). This measure of thymic function may also
facilitate the design of studies aimed at augmenting in-
trathymic T cell production.
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